- Price
- $88.75
- Day
- -0.10%
- Mkt Cap
- $15.37B
- 52W Range
- $62.38 – $94.16
- Volume
- 651.2K
- Beta
- 0.69
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Solventum trades at a significant discount to medical technology peers, with a forward P/E of ~13x and suppressed EV/EBITDA multiples. Management is executing a portfolio optimization, including a potential spin-off of the Health Information Systems segment to unlock value and reduce debt. Raised 2026 EPS guidance to $7.10-$7.20 and operating margins to 22.2%-22.7%, signaling margin expansion and improved free cash flow allocation.
Read full article
Tidal Investments LLC trimmed its position in Solventum Corporation (NYSE: SOLV) by 25.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 23,333 shares of the company's stock after selling 7,781 shares during the quarter. Tidal Investments LLC's holdings in Solventum were
Read full article
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read full article
SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.
Read full article
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Read full article
Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Read full article
Solventum (SOLV) reported earnings 30 days ago. What's next for the stock?
Read full article
Shares of Solventum Corporation (NYSE: SOLV - Get Free Report) have been given an average recommendation of "Moderate Buy" by the thirteen analysts that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and eight have issued a buy
Read full article
EAGAN, Minn., Sept. 2, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, Sept.
Read full article
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Read full article
Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.
Read full article